Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2017-06-08

Clinical Trial Update: Effects of an Antioxidant-Enriched Multivitamin Supplement on Inflammation and Oxidative Stress in Cystic Fibrosis [Phase 2]

View source ↗

Summary

Phase 2 trial evaluated an antioxidant-enriched multivitamin for reducing inflammation and oxidative stress in cystic fibrosis; results have been posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Antioxidant-Enriched Multivitamin Supplement

Snippet

Sponsor: University of Colorado, Denver | Conditions: Cystic Fibrosis | Phase 2 | Status: COMPLETED | Results posted: 2017-06-08